Table 1 Clinical and pathological data of group 1 and group 2 patients
Parameter | Group 1 (n = 28) | Group 2 (n = 26) | ||
|---|---|---|---|---|
Primary HCC | Site | Exophitic | 39.3% | 30.8% |
Subcapsular | 7.1% | 11.5% | ||
Deep | 53.6% | 57.7% | ||
Primary treatment | Resection | 82.1% | 100% | |
PEI/RFA | 17.9% | 0% | ||
Tumor violation | Needle tract injury | 53.6% | 7.7 | |
Spontaneous HCC rupture | 14.3% | 0% | ||
TACE | 3.6% | 0% | ||
No violation | 28.6% | 92.3% | ||
Number of PPL/extrahepatic lesions | Â | Single | 53.6% | 0% |
Multiple | 46.4% | 100% | ||
Intrahepatic-associated recurrences | Â | Â | 60.7% | 53.8% |
Delay of appearance of recurrence after the primary treatment (months) | After resection | Mean | 20 | 13 |
| Â | Range | 1-45 | 2-44 | |
After PB/PEI/RFA | Mean | 15 | – | |
Range | 4-23 | – | ||